Sponsor Pipeline

Alto Neuroscience Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
4
Recruiting
3
Disease Areas
Active Trials by Phase
Phase 2
4
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06656416 ALTO-100 in Bipolar Disorder With Depression (BD-D) Bipolar Disorder I or II With a Major Depressive Episode Recruiting
NCT05922878 Study of ALTO-300 in MDD Major Depressive Disorder Recruiting
NCT06502964 Study of ALTO-101 in Patients With Schizophrenia Schizophrenia Recruiting
NCT07553637 ALTO-207 in Adults With Treatment-resistant Depression (TRD) Treatment-resistant Depression (TRD) Recruiting
Disease Areas
Depression (2) Schizophrenia (1) Bipolar Disorder (1)
Get alerts when Alto Neuroscience's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free